{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:26:25Z","timestamp":1778613985880,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing University of Agricultural for Young Teachers' Research and Innovation Ability Improvement Plan","award":["QJKC2022025"],"award-info":[{"award-number":["QJKC2022025"]}]},{"name":"Open scientific research project of China Animal Husbandry Corporation","award":["(2002)00905"],"award-info":[{"award-number":["(2002)00905"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32072898"],"award-info":[{"award-number":["32072898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03447-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:41:19Z","timestamp":1748356879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nanoparticle-mediated SIRT1 inhibition suppresses M2 macrophage polarization and hepatocarcinogenesis in chronic hepatitis B"],"prefix":"10.1186","volume":"23","author":[{"given":"He","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyou","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"3447_CR1","doi-asserted-by":"publisher","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J et al. Global burden of primary liver cancer in 2020 and predictions to 2040 [Internet]. Journal of Hepatology. Elsevier BV; 2022 [cited 2025 Apr 11]. pp. 1598\u2013606. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021","DOI":"10.1016\/j.jhep.2022.08.021"},{"key":"3447_CR2","volume-title":"Hepatocellular carcinoma. StatPearls","author":"KO Asafo-Agyei","year":"2023","unstructured":"Asafo-Agyei KO, Samant H. Hepatocellular carcinoma. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"3447_CR3","doi-asserted-by":"publisher","unstructured":"Lee H-Y, Nga HT, Tian J, Yi H-S. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma [Internet]. Cells. MDPI AG; 2021 [cited 2025 Apr 11]. p. 1901. Available from: https:\/\/doi.org\/10.3390\/cells10081901","DOI":"10.3390\/cells10081901"},{"key":"3447_CR4","doi-asserted-by":"publisher","unstructured":"Xia Z, Zhang J, Chen W, Zhou H, Du D, Zhu K et al. Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis [Internet]. Infect Dis Poverty. Springer Science and Business Media LLC; 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1186\/s40249-023-01128-6","DOI":"10.1186\/s40249-023-01128-6"},{"key":"3447_CR5","doi-asserted-by":"publisher","unstructured":"Tian F, Feld JJ, Feng Z, Sander B, Wong WWL. Feasibility of hepatitis B elimination in high-income countries with ongoing immigration [Internet]. Journal of Hepatology. Elsevier BV; 2022 [cited 2025 Apr 11]. pp. 947\u201356. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2022.04.014","DOI":"10.1016\/j.jhep.2022.04.014"},{"key":"3447_CR6","doi-asserted-by":"publisher","unstructured":"Jeng W-J, Papatheodoridis GV, Lok ASF, Hepatitis B [Internet]. The Lancet., Elsevier BV. 2023 [cited 2025 Apr 11]. pp. 1039\u201352. Available from: https:\/\/doi.org\/10.1016\/s0140-6736(22)01468-4","DOI":"10.1016\/s0140-6736(22)01468-4"},{"key":"3447_CR7","doi-asserted-by":"publisher","unstructured":"Lee HW, Lee JS, Ahn SH, Hepatitis B. Virus Cure: Targets and Future Therapies [Internet]. IJMS. MDPI AG; 2020 [cited 2025 Apr 11]. p. 213. Available from: https:\/\/doi.org\/10.3390\/ijms22010213","DOI":"10.3390\/ijms22010213"},{"key":"3447_CR8","doi-asserted-by":"publisher","unstructured":"Chien R-N, Liaw Y-F. Current Trend in Antiviral Therapy for Chronic Hepatitis B [Internet]. Viruses. MDPI AG; 2022 [cited 2025 Apr 11]. p. 434. Available from: https:\/\/doi.org\/10.3390\/v14020434","DOI":"10.3390\/v14020434"},{"key":"3447_CR9","doi-asserted-by":"publisher","unstructured":"Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression [Internet]. IJMS. MDPI AG; 2021 [cited 2025 Apr 11]. p. 5497. Available from: https:\/\/doi.org\/10.3390\/ijms22115497","DOI":"10.3390\/ijms22115497"},{"key":"3447_CR10","doi-asserted-by":"publisher","unstructured":"Jiang P, Jia H, Qian X, Tang T, Han Y, Zhang Z et al. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B [Internet]. Hepatology. Ovid Technologies (Wolters Kluwer Health); 2023 [cited 2025 Apr 11]. pp. 167\u201382. Available from: https:\/\/doi.org\/10.1097\/hep.0000000000000524","DOI":"10.1097\/hep.0000000000000524"},{"key":"3447_CR11","doi-asserted-by":"publisher","unstructured":"Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A et al. Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis [Internet]. Hepatology. Ovid Technologies (Wolters Kluwer Health); 2022 [cited 2025 Apr 11]. pp. 1348\u201365. Available from: https:\/\/doi.org\/10.1002\/hep.32731","DOI":"10.1002\/hep.32731"},{"key":"3447_CR12","doi-asserted-by":"publisher","unstructured":"Roca Suarez AA, Testoni B, Zoulim FHBV. 2021: New therapeutic strategies against an old foe [Internet]. Liver International. Wiley; 2021 [cited 2025 Apr 11]. pp. 15\u201323. Available from: https:\/\/doi.org\/10.1111\/liv.14851","DOI":"10.1111\/liv.14851"},{"key":"3447_CR13","unstructured":"loading [Internet]. Available from: http:\/\/journal.yiigle.com\/LinkIn.do?linkin_type=DOI&DOI=10.3760\/cma.j.cn501113-20230316-00117"},{"key":"3447_CR14","doi-asserted-by":"publisher","unstructured":"Luo X, He X, Zhang X, Zhao X, Zhang Y, Shi Y et al. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy [Internet]. MedComm. Wiley; 2024 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1002\/mco2.474","DOI":"10.1002\/mco2.474"},{"key":"3447_CR15","doi-asserted-by":"publisher","unstructured":"Antonucci L, Canciani G, Mastronuzzi A, Carai A, Del Baldo G, Del Bufalo F. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies [Internet]. Front. Immunol. Frontiers Media SA; 2022 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.3389\/fimmu.2022.867154","DOI":"10.3389\/fimmu.2022.867154"},{"key":"3447_CR16","doi-asserted-by":"publisher","unstructured":"Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H et al. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin [Internet]. J Hematol Oncol. Springer Science and Business Media LLC; 2021 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1186\/s13045-021-01128-9","DOI":"10.1186\/s13045-021-01128-9"},{"key":"3447_CR17","doi-asserted-by":"publisher","unstructured":"Kong F-H, Ye Q-F, Miao X-Y, Liu X, Huang S-Q, Xiong L et al. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma [Internet]. Theranostics. Ivyspring International Publisher; 2021 [cited 2025 Apr 11]. pp. 5464\u201390. Available from: https:\/\/doi.org\/10.7150\/thno.54822","DOI":"10.7150\/thno.54822"},{"key":"3447_CR18","doi-asserted-by":"publisher","unstructured":"Yang R, Gao W, Wang Z, Jian H, Peng L, Yu X et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis [Internet]. Phytomedicine. Elsevier BV; 2024 [cited 2025 Apr 11]. p. 155135. Available from: https:\/\/doi.org\/10.1016\/j.phymed.2023.155135","DOI":"10.1016\/j.phymed.2023.155135"},{"key":"3447_CR19","doi-asserted-by":"publisher","unstructured":"Alawyia B, Constantinou C. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects [Internet]. Curr. Treat. Options in Oncol. Springer Science and Business Media LLC; 2023 [cited 2025 Apr 11]. pp. 711\u201324. Available from: https:\/\/doi.org\/10.1007\/s11864-023-01098-9","DOI":"10.1007\/s11864-023-01098-9"},{"key":"3447_CR20","doi-asserted-by":"publisher","unstructured":"Di Benedetto F, Magistri P, Di Sandro S, Sposito C, Oberkofler C, Brandon E et al. Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma [Internet]. JAMA Surg. American Medical Association (AMA); 2023 [cited 2025 Apr 11]. p. 46. Available from: https:\/\/doi.org\/10.1001\/jamasurg.2022.5697","DOI":"10.1001\/jamasurg.2022.5697"},{"key":"3447_CR21","doi-asserted-by":"publisher","unstructured":"Esp\u00edrito Santo J, Ladeirinha A, Alarc\u00e3o A, Strelet E, Reis M, Santos R et al. Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy [Internet]. Med Oncol. Springer Science and Business Media LLC; 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1007\/s12032-023-02208-1","DOI":"10.1007\/s12032-023-02208-1"},{"key":"3447_CR22","doi-asserted-by":"publisher","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma [Internet]. The Lancet., Elsevier BV. 2022 [cited 2025 Apr 11]. pp. 1345\u201362. Available from: https:\/\/doi.org\/10.1016\/s0140-6736(22)01200-4","DOI":"10.1016\/s0140-6736(22)01200-4"},{"key":"3447_CR23","doi-asserted-by":"publisher","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification [Internet]. Advances in Cancer Research. Elsevier; 2021 [cited 2025 Apr 11]. pp. 1\u201361. Available from: https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001","DOI":"10.1016\/bs.acr.2020.10.001"},{"key":"3447_CR24","doi-asserted-by":"publisher","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM et al. Management of Hepatocellular Carcinoma [Internet]. JAMA Surg. American Medical Association (AMA); 2023 [cited 2025 Apr 11]. p. 410. Available from: https:\/\/doi.org\/10.1001\/jamasurg.2022.7989","DOI":"10.1001\/jamasurg.2022.7989"},{"key":"3447_CR25","doi-asserted-by":"publisher","unstructured":"Li J, Xuan S, Dong P, Xiang Z, Gao C, Li M et al. Immunotherapy of hepatocellular carcinoma: recent progress and new strategy [Internet]. Front. Immunol. Frontiers Media SA; 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.3389\/fimmu.2023.1192506","DOI":"10.3389\/fimmu.2023.1192506"},{"key":"3447_CR26","doi-asserted-by":"publisher","unstructured":"Javed YS. Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm [Internet]. Med Oncol. Springer Science and Business, Media LLC. 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1007\/s12032-023-02104-8","DOI":"10.1007\/s12032-023-02104-8"},{"key":"3447_CR27","doi-asserted-by":"publisher","unstructured":"Eghbali S, Heumann TR. Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches [Internet]. Cancers. MDPI AG; 2025 [cited 2025 Apr 11]. p. 236. Available from: https:\/\/doi.org\/10.3390\/cancers17020236","DOI":"10.3390\/cancers17020236"},{"key":"3447_CR28","doi-asserted-by":"publisher","unstructured":"Finn RS, Galle PR, Ducreux M, Cheng A-L, Reilly N, Nicholas A, Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and\/or Contralateral Portal Vein Invasion in IMbrave150 [Internet]. Liver Cancer., Karger S et al. AG; 2024 [cited 2025 Apr 11]. pp. 1\u201314. Available from: https:\/\/doi.org\/10.1159\/000539897","DOI":"10.1159\/000539897"},{"key":"3447_CR29","doi-asserted-by":"publisher","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma [Internet]. N Engl J Med. Massachusetts Medical Society; 2020 [cited 2025 Apr 11]. pp. 1894\u2013905. Available from: https:\/\/doi.org\/10.1056\/nejmoa1915745","DOI":"10.1056\/nejmoa1915745"},{"key":"3447_CR30","doi-asserted-by":"publisher","unstructured":"Vogel A, Meyer T, Saborowski A. IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma [Internet]. The Lancet. Elsevier BV; 2023 [cited 2025 Apr 11]. pp. 1806\u20137. Available from: https:\/\/doi.org\/10.1016\/s0140-6736(23)01962-1","DOI":"10.1016\/s0140-6736(23)01962-1"},{"key":"3447_CR31","doi-asserted-by":"publisher","unstructured":"Crespo M, Nikolic I, Mora A, Rodr\u00edguez E, Leiva-Vega L, Pintor\u2010Chocano A et al. Myeloid p38 activation maintains macrophage\u2013liver crosstalk and BAT thermogenesis through IL\u201012\u2013FGF21 axis [Internet]. Hepatology. Ovid Technologies (Wolters Kluwer Health); 2023 [cited 2025 Apr 11]. pp. 874\u201387. Available from: https:\/\/doi.org\/10.1002\/hep.32581","DOI":"10.1002\/hep.32581"},{"key":"3447_CR32","doi-asserted-by":"publisher","unstructured":"Ma C, Feng K, Yang X, Yang Z, Wang Z, Shang Y et al. Targeting macrophage liver X receptors by hydrogel-encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis [Internet]. British J Pharmacology. Wiley; 2021 [cited 2025 Apr 11]. pp. 1620\u201338. Available from: https:\/\/doi.org\/10.1111\/bph.15387","DOI":"10.1111\/bph.15387"},{"key":"3447_CR33","doi-asserted-by":"publisher","unstructured":"Cheng P, Li S, Chen H. Macrophages in Lung Injury, Repair, and Fibrosis [Internet]. Cells. MDPI AG; 2021 [cited 2025 Apr 11]. p. 436. Available from: https:\/\/doi.org\/10.3390\/cells10020436","DOI":"10.3390\/cells10020436"},{"key":"3447_CR34","doi-asserted-by":"publisher","unstructured":"Wu H, Zheng J, Xu S, Fang Y, Wu Y, Zeng J et al. Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury [Internet]. J Neuroinflammation. Springer Science and Business Media LLC; 2021 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1186\/s12974-020-02041-7","DOI":"10.1186\/s12974-020-02041-7"},{"key":"3447_CR35","doi-asserted-by":"publisher","unstructured":"Wu M-M, Wang Q-M, Huang B-Y, Mai C-T, Wang C-L, Wang T-T et al. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization [Internet]. Pharmacological Research. Elsevier BV; 2021 [cited 2025 Apr 11]. p. 105796. Available from: https:\/\/doi.org\/10.1016\/j.phrs.2021.105796","DOI":"10.1016\/j.phrs.2021.105796"},{"key":"3447_CR36","doi-asserted-by":"publisher","unstructured":"Tu Y, Liu J, Kong D, Guo X, Li J, Long Z, Irisin drives macrophage anti-inflammatory differentiation via JAK2-STAT6-dependent activation of PPAR\u03b3 and Nrf2 signaling [Internet]. Free Radical Biology and Medicine., Elsevier BV et al. 2023 [cited 2025 Apr 11]. pp. 98\u2013110. Available from: https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.014","DOI":"10.1016\/j.freeradbiomed.2023.03.014"},{"key":"3447_CR37","doi-asserted-by":"publisher","unstructured":"Wu H, Dong H, Tang Z, Chen Y, Liu Y, Wang M et al. Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory polarization of macrophages and bone repair via MAPK\/JNK inhibition and OXPHOS activation [Internet]. Biomaterials. Elsevier BV; 2023 [cited 2025 Apr 11]. p. 121990. Available from: https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121990","DOI":"10.1016\/j.biomaterials.2022.121990"},{"key":"3447_CR38","doi-asserted-by":"publisher","unstructured":"Wang Y, Wang J, Gao R, Liu X, Feng Z, Zhang C et al. Biomimetic glycopeptide hydrogel coated PCL\/nHA scaffold for enhanced cranial bone regeneration via macrophage M2 polarization-induced osteo-immunomodulation [Internet]. Biomaterials. Elsevier BV; 2022 [cited 2025 Apr 11]. p. 121538. Available from: https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121538","DOI":"10.1016\/j.biomaterials.2022.121538"},{"key":"3447_CR39","doi-asserted-by":"publisher","unstructured":"Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis [Internet]. Nat Commun. Springer Science and Business Media LLC; 2022 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1038\/s41467-022-33349-y","DOI":"10.1038\/s41467-022-33349-y"},{"key":"3447_CR40","doi-asserted-by":"publisher","unstructured":"Yu Z, Li Y, Li Y, Zhang J, Li M, Ji L et al. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma [Internet]. J Immunother Cancer. BMJ; 2022 [cited 2025 Apr 11]. p. e004297. Available from: https:\/\/doi.org\/10.1136\/jitc-2021-004297","DOI":"10.1136\/jitc-2021-004297"},{"key":"3447_CR41","doi-asserted-by":"publisher","unstructured":"Ou D-L, Chen C-W, Hsu C-L, Chung C-H, Feng Z-R, Lee B-S et al. Regorafenib enhances antitumor immunity via inhibition of p38 kinase\/Creb1\/Klf4 axis in tumor-associated macrophages [Internet]. J Immunother Cancer. BMJ; 2021 [cited 2025 Apr 11]. p. e001657. Available from: https:\/\/doi.org\/10.1136\/jitc-2020-001657","DOI":"10.1136\/jitc-2020-001657"},{"key":"3447_CR42","doi-asserted-by":"publisher","unstructured":"Zou Y, Wang Y, Xu S, Liu Y, Yin J, Lovejoy DB et al. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy [Internet]. Advanced Materials. Wiley; 2022 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1002\/adma.202203958","DOI":"10.1002\/adma.202203958"},{"key":"3447_CR43","doi-asserted-by":"publisher","unstructured":"Huang R-Y, Liu Z-H, Weng W-H, Chang C-W. Magnetic nanocomplexes for gene delivery applications [Internet]. J. Mater. Chem. B. Royal Society of Chemistry (RSC); 2021 [cited 2025 Apr 11]. pp. 4267\u201386. Available from: https:\/\/doi.org\/10.1039\/d0tb02713h","DOI":"10.1039\/d0tb02713h"},{"key":"3447_CR44","doi-asserted-by":"publisher","unstructured":"Hu L, Tao Y, Jiang Y, Qin F. Recent progress of nanomedicine in the treatment of Alzheimer\u2019s disease [Internet]. Front. Cell Dev. Biol. Frontiers Media SA; 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.3389\/fcell.2023.1228679","DOI":"10.3389\/fcell.2023.1228679"},{"key":"3447_CR45","doi-asserted-by":"publisher","unstructured":"Huang Y, Zhang C, Zhang L, Chen X, Fan W. Chemical Synthesis and Multihybridization of Small-Sized Hollow Mesoporous Organosilica Nanoparticles Toward Advanced Theranostics [Internet]. Acc. Chem. Res. American Chemical Society (ACS); 2024 [cited 2025 Apr 11]. pp. 3465\u201377. Available from: https:\/\/doi.org\/10.1021\/acs.accounts.4c00502","DOI":"10.1021\/acs.accounts.4c00502"},{"key":"3447_CR46","doi-asserted-by":"publisher","unstructured":"Kovtareva S, Kusepova L, Tazhkenova G, Mashan T, Bazarbaeva K, Kopishev E. Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs [Internet]. Polymers. MDPI AG; 2024 [cited 2025 Apr 11]. p. 1105. Available from: https:\/\/doi.org\/10.3390\/polym16081105","DOI":"10.3390\/polym16081105"},{"key":"3447_CR47","doi-asserted-by":"publisher","unstructured":"Peck B, Chen C-Y, Ho K-K, Di Fruscia P, Myatt SS, Coombes RC et al. SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2 [Internet]. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2010 [cited 2025 Apr 11]. pp. 844\u201355. Available from: https:\/\/doi.org\/10.1158\/1535-7163.mct-09-0971","DOI":"10.1158\/1535-7163.mct-09-0971"},{"key":"3447_CR48","doi-asserted-by":"publisher","unstructured":"GHATREH SAMANI K, FARROKHI E, TABATABAEE A, JALILIAN N. JAFARI M. Synergistic Effects of Lauryl Gallate and Tamoxifen on Human Breast Cancer Cell [Internet]. ijph. Knowledge E DMCC; 2020 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.18502\/ijph.v49i7.3586","DOI":"10.18502\/ijph.v49i7.3586"},{"key":"3447_CR49","doi-asserted-by":"publisher","unstructured":"Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y et al. Regulation of SIRT1 and Its Roles in Inflammation [Internet]. Front. Immunol. Frontiers Media SA; 2022 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.3389\/fimmu.2022.831168","DOI":"10.3389\/fimmu.2022.831168"},{"key":"3447_CR50","doi-asserted-by":"publisher","unstructured":"Wei Z, Xia J, Li J, Cai J, Shan J, Zhang C et al. SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma [Internet]. Int. J. Biol. Sci. Ivyspring International Publisher; 2023 [cited 2025 Apr 11]. pp. 1925\u201340. Available from: https:\/\/doi.org\/10.7150\/ijbs.76704","DOI":"10.7150\/ijbs.76704"},{"key":"3447_CR51","doi-asserted-by":"publisher","unstructured":"Zhao B, Li X, Zhou L, Wang Y, Shang P. SIRT1: a potential tumour biomarker and therapeutic target [Internet]. Journal of Drug Targeting. Informa UK Limited; 2019 [cited 2025 Apr 11]. pp. 1046\u201352. Available from: https:\/\/doi.org\/10.1080\/1061186x.2019.1605519","DOI":"10.1080\/1061186x.2019.1605519"},{"key":"3447_CR52","doi-asserted-by":"publisher","unstructured":"Liu H, Duan C, Yang X, Liu J, Deng Y, Tiselius H-G, Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation [Internet]. Sig Transduct Target Ther. Springer Science and Business, Media LLC et al. 2023 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1038\/s41392-022-01232-3","DOI":"10.1038\/s41392-022-01232-3"},{"key":"3447_CR53","doi-asserted-by":"publisher","unstructured":"Wang X, Song X, Fang K, Chang X. CD38 modulates cytokine secretion by NK cells through the Sirt1\/NF-\u03baB pathway, suppressing immune surveillance in colorectal cancer [Internet]. Sci Rep. Springer Science and Business Media LLC; 2024 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1038\/s41598-024-79008-8","DOI":"10.1038\/s41598-024-79008-8"},{"key":"3447_CR54","doi-asserted-by":"publisher","unstructured":"Lin S-C, Liao Y-C, Chen P-M, Yang Y-Y, Wang Y-H, Tung S-L, Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling [Internet]. J Biomed Sci. Springer Science and Business, Media LLC et al. 2022 [cited 2025 Apr 11]. Available from: https:\/\/doi.org\/10.1186\/s12929-022-00888-x","DOI":"10.1186\/s12929-022-00888-x"},{"key":"3447_CR55","doi-asserted-by":"publisher","unstructured":"Wang J, Bai J, Wang Y, Zhang K, Li Y, Qian H et al. Feruloylated arabinoxylan from wheat bran inhibited M1-macrophage activation and enhanced M2-macrophage polarization [Internet]. International Journal of Biological Macromolecules. Elsevier BV; 2022 [cited 2025 Apr 11]. pp. 993\u20131001. Available from: https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.11.158","DOI":"10.1016\/j.ijbiomac.2021.11.158"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03447-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03447-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03447-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:41:20Z","timestamp":1748356880000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03447-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03447-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Beijing University of Agriculture (No. BUA812403010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}